TWC
ABCL icon

TD Waterhouse Canada’s AbCellera Biologics ABCL Stock Holding History

TD Waterhouse Canada’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.6M Buy
9,568,149
+3,490
+0% +$17.1K 0.19% 93
2026
Q1 		$33.6M Buy
9,564,659
+9,542,247
+42,577% +$34.3M 0.1% 140
2025
Q4 		$76.4K Sell
22,412
-2,126
-9% -$9.49K ﹤0.01% 1096
2025
Q3 		$146K Buy
24,538
+1,185
+5% +$5.22K ﹤0.01% 943
2025
Q2 		$81.3K Sell
23,353
-87
-0.4% -$217 ﹤0.01% 1013
2025
Q1 		$48.7K Sell
23,440
-81,154
-78% -$233K ﹤0.01% 1096
2024
Q4 		$306K Sell
104,594
-127,830
-55% -$356K ﹤0.01% 714
2024
Q3 		$595K Sell
232,424
-13,180
-5% -$36.5K ﹤0.01% 585
2024
Q2 		$681K Sell
245,604
-12,718
-5% -$48.1K 0.01% 549
2024
Q1 		$1.13M Buy
258,322
+192
+0.1% +$980 0.01% 480
2023
Q4 		$1.58M Sell
258,130
-71,471
-22% -$331K 0.01% 358
2023
Q3 		$1.52M Sell
329,601
-244,314
-43% -$1.49M 0.02% 355
2023
Q2 		$4.24M Buy
573,915
+91,282
+19% +$623K 0.04% 230
2023
Q1 		$4.25M Sell
482,633
-30,931
-6% -$281K 0.04% 224
2022
Q4 		$5.77M Sell
513,564
-14,096
-3% -$163K 0.06% 182
2022
Q3 		$6.36M Buy
527,660
+173,184
+49% +$1.9M 0.07% 162
2022
Q2 		$4.55M Sell
354,476
-2,150
-0.6% -$18.2K 0.05% 208
2022
Q1 		$4.28M Buy
356,626
+175,671
+97% +$1.66M 0.04% 232
2021
Q4 		$2.84M Buy
+180,955
New +$2.75M 0.03% 309

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

TD Waterhouse Canada's ABCL Position: Q2 2026 in Review

TD Waterhouse Canada increased its AbCellera Biologics (ABCL) stake by 0.04% in Q2 2026, buying an estimated $17.1K and bringing the position to 9,568,149 shares worth $72.6M. The position accounts for 0.19% of the portfolio, ranked #93.

TD Waterhouse Canada first reported a position in ABCL in Q4 2021 and has held it in 19 quarters since. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • TD Waterhouse Canada held 9,568,149 shares of AbCellera Biologics worth $72.6M as of Q2 2026.
  • TD Waterhouse Canada bought 3,490 AbCellera Biologics shares in Q2 2026, an estimated $17.1K.
  • AbCellera Biologics made up 0.19% of TD Waterhouse Canada's portfolio in Q2 2026, its #93 holding.
  • TD Waterhouse Canada first reported a position in AbCellera Biologics in Q4 2021 and has held it in 19 quarters since.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.